# Qishenyiqi Dripping Pill for Coronary Microvascular Disease

> **NCT06699420** · PHASE4 · RECRUITING · sponsor: **Qilu Hospital of Shandong University** · enrollment: 162 (estimated)

## Conditions studied

- Coronary Microvascular Disease

## Interventions

- **DRUG:** Qishenyiqi dripping pills 1 bag, three times a day
- **DRUG:** Placebo 1 bag, three times a day

## Key facts

- **NCT ID:** NCT06699420
- **Lead sponsor:** Qilu Hospital of Shandong University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-08
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-06-30
- **Target enrollment:** 162 (ESTIMATED)
- **Last updated:** 2024-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06699420

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06699420, "Qishenyiqi Dripping Pill for Coronary Microvascular Disease". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06699420. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*